Under the leadership of founder Stuart Cairns, an accomplished investment banker, Manuka has consistently met benchmarks in its quest to conquer the Manuka oil supply chain – from growing Manuka trees to processing oils and ultimately distributing Manuka oil in global markets.
Manuka oil has broad spectrum antibacterial, antifungal, antiviral, anti-inflammatory, antioxidant, anti-aging and wound healing properties. These properties have been investigated by global research teams and documented in over 1,000 peer reviewed publications over the last 25 years.
Manuka Bioscience, the largest producer of manuka oil in the world, is leveraging this existing body of knowledge and developing a number of high efficacy antibacterial and antiviral products that will have a low impact on antimicrobial resistance, a massive global threat. Manuka Bioscience is developing proprietary ingredients from manuka oil, two of which are currently in clinical trials, and have the potential for significant value creation.
